Pharmaceuticals

Ministry stays DCGI ban on Natco's generic cancer drug

11 Jan 2010

GSK inching closer to deal with Dr Reddy's?

08 Jan 2010

EU launches probe against Lundbeck for stalling generic drugs

08 Jan 2010

Orchid receives tentative FDA approval for Alzheimer’s drug Memantine tablet

08 Jan 2010

AstraZeneca settles another Nexium patent litigation for US sales

07 Jan 2010

Pfizer to market 40 Strides Arcolab generic drugs in the US

07 Jan 2010

The world's largest drugmaker, Pfizer has struck a collaboration deal yesterday to sell 40 generic drugs manufactured by Strides Arcolab of India to expand the its  generics business in the US

Wockhardt gets US FDA approval for Alzheimer's drug Memantine

06 Jan 2010

Dr Reddy’s all-new diabetes drug shows good results

06 Jan 2010

Germany's Merz Pharmaceuticals to acquire BioForm Medical for $253 million

04 Jan 2010

Novartis acquires 52 per cent additional stake in Alcon for $28.1 billion

04 Jan 2010

Novartis, which acquired a 25 per cent stake in Nestle-owned Alcon for $11 billion in April 2008, is exercising its call option to buy an additional 52 per cent stake for $180 per share in the eye-care giant.

Sun fails to dislodge Taro directors at general body

01 Jan 2010

India's Sun Pharmaceutical Industries claimed partial success in its fight against the management of Israeli generic-drugs maker Taro Pharmaceutical Industries when most minority shareholders of Taro voted against re-election of its board members.

Ranbaxy sells Chinese JV stake to state-owned firm

29 Dec 2009

Dr Reddy's to launch new drugs to boost domestic operations

28 Dec 2009

DCGI asks GSK to withdraw promotional campaign

26 Dec 2009

Ranbaxy again feels FDA heat – this time over US plant

26 Dec 2009

Teva-Kowa Pharma to acquire majority stake in Japanese genrics maker Taisho

24 Dec 2009

Boston Scientific pays $22 million to settle DOJ probe on kickbacks

24 Dec 2009

AstraZeneca to acquire Novexel for $350 million, expand alliance with Forest Labs

24 Dec 2009

Novartis acquires Corthera, gets global rights to new heart drug

23 Dec 2009

Glass Lewis supports Sun in Taro battle

23 Dec 2009

Legal advisory and proxy services firm Glass Lewis has called on Taro shareholders to vote against all the resolutions proposed by the management at the shareholders meeting on 31 December

Lupin settles dispute with Forest Labs over Namenda

22 Dec 2009

Templeton cold to Taro’s plea for protection against Sun

22 Dec 2009

Though initially opposed to the idea of a Sun takeover, Mobius recently threw his weight behind the Indian pharma giant, citing Taro’s lack of clarity in its financials

Seattle Genetics in antibody development deal with GSK

22 Dec 2009

Sanofi-aventis to acquire Chattem for $1.9 billion

21 Dec 2009

The acquisition would help the French drug firm move up a rank to the world's fifth  largest drug maker

Ranbaxy to launch anti-hypertensive drug in six African countries

21 Dec 2009

The product to be marketed under the brand name Olvance would be launched immediately on completion of the required formalities in each country